BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1790 related articles for article (PubMed ID: 11686108)

  • 1. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiology of thrombotic microangiopathies: current understanding].
    Coppo P; Veyradier A; Durey MA; Fremeaux-Bacchi V; Scrobohaci ML; Amesland F; Bussel A
    Ann Med Interne (Paris); 2002 May; 153(3):153-66. PubMed ID: 12218898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
    Byrnes JJ; Moake JL
    Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.
    Furlan M; Robles R; Solenthaler M; Lämmle B
    Blood; 1998 Apr; 91(8):2839-46. PubMed ID: 9531594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
    Furlan M
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of von Willebrand protease in aetiopathogenesis of thrombotic thrombocytopenic purpura].
    Suvajdzić-Vuković N
    Srp Arh Celok Lek; 2007; 135(5-6):360-6. PubMed ID: 17633329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Moake JL; McPherson PD
    Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura.
    Furlan M; Lämmle B
    Baillieres Clin Haematol; 1998 Jun; 11(2):509-14. PubMed ID: 10097823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombotic thrombocytopenic purpura in children -- pathophysiologic mechanisms and their clinical significance].
    Korczowski B
    Med Wieku Rozwoj; 2005; 9(4):753-61. PubMed ID: 16733283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets: thrombotic thrombocytopenic purpura.
    George JN; Sadler JE; Lämmle B
    Hematology Am Soc Hematol Educ Program; 2002; ():315-34. PubMed ID: 12446430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
    Tsai HM; Lian EC
    N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand factor and thrombotic thrombocytopenic purpura.
    Raife TJ; Montgomery RR
    Curr Opin Hematol; 2000 Sep; 7(5):278-83. PubMed ID: 10961577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The von Willebrand factor-cleaving protease (ADAMTS-13) and the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Kremer Hovinga JA; Studt JD; Lämmle B
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):417-21. PubMed ID: 15692254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
    Schiphorst RH; van de Kar NC; van den Heuvel LP
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.
    Furlan M; Robles R; Solenthaler M; Wassmer M; Sandoz P; Lämmle B
    Blood; 1997 May; 89(9):3097-103. PubMed ID: 9129011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
    Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B
    Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy.
    Arai S; Allan C; Streiff M; Hutchins GM; Vogelsang GB; Tsai HM
    Hematol J; 2001; 2(5):292-9. PubMed ID: 11920264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    George JN
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):627-32. PubMed ID: 16167049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 90.